Literature DB >> 12923674

[Comorbidity, multiple medication, and well-being in elderly patients with chronic pain].

H D Basler1, S Hesselbarth, G Kaluza, M Schuler, W Sohn, Th Nikolaus.   

Abstract

Consecutive patients with a minimum age of 65 years and at least one additional diagnosis participated in a standardized interview during the initial assessments in two geriatric hospitals ( n=86), a multidisciplinary pain center ( n=60), and three primary care practices ( n=117). The average age of the total sample was 76.29 years (SD=7.40); females constituted 73.3% of the sample. The average number of drugs consumed by the patients amounted to 7.31 (SD=2.66) with a maximum number of 19 drugs. Nearly three-quarters of the patients indicated a reduction in their pain by avoiding physical activity. Every second patient often felt depressed and without energy. The most frequent symptoms were a dry mouth, sleep disorders, fatigue, constipation, and dizziness. Patients from the geriatric hospitals were older and better educated, reported fewer painful body regions, indicated lower intensity and duration of pain as well as a lower number of pain medications. On the other hand, they were characterized by a higher intensity of comorbidity and by increased functional impairment. Patients from the pain clinic suffered more frequently from pain in the hip and the pelvis. They took stage I analgesics more often and admitted more frequently to adjusting the drug consumption to changes in well-being and situational factors. They felt the highest amount of impairment in their social activities. Nevertheless, they expressed the highest confidence in future improvement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923674     DOI: 10.1007/s00482-003-0231-0

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  15 in total

1.  [Pain and fear of movement in the elderly : the need for an interdisciplinary approach].

Authors:  C Leonhardt; M Laekeman
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

Review 2.  [Activating physiotherapy for chronic pain in elderly patients. Recommendations, barriers and resources].

Authors:  K Kuss; M Laekeman
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

3.  [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].

Authors:  C Wolfert; M Merbach; G Stammler; O Emrich; A D Meid; J Burhenne; A Blank; G Mikus
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

4.  [Pain management in elderly patients].

Authors:  F Luttosch; C Baerwald
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

Review 5.  [Pharmacological treatment of osteoarthritis in the elderly].

Authors:  T Brabant; D Stichtenoth
Journal:  Z Rheumatol       Date:  2005-10       Impact factor: 1.372

6.  [Influence of pain perception, morbidity and mood on functional impairment in elderly chronic pain patients].

Authors:  Matthias S Schuler; H D Basler; S Hesselbarth; G Kaluza; W Sohn; Th Nikolaus
Journal:  Z Gerontol Geriatr       Date:  2004-08       Impact factor: 1.281

7.  [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].

Authors:  W Häuser; C Zimmer; E Felde; V Köllner
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

8.  [Multimodal group therapy for the elderly with chronic pain: concept and results in a before and after comparison].

Authors:  P Mattenklodt; A Ingenhorst; C Wille; B Flatau; C Hafner; C Geiss; R Sittl; K Ulrich; N Griessinger
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

Review 9.  [Diagnostics of pain in old age. Perspectives on a multidimensional phenomenon].

Authors:  E Sirsch; I Gnass; T Fischer
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

10.  [Opioids for noncancer pain in the elderly].

Authors:  M Schuler; N Grießinger
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.